RAR and RXR modulation in cancer and metabolic disease

被引：437

作者：

Altucci, Lucia

Leibowitz, Mark D.

Ogilvie, Kathleen M.

de Lera, Angel R.

Gronemeyer, Hinrich

机构：

[1] Dipartimento di Patologia Generale, Seconda Università degli Studi di Napoli, 80138 Napoli

[2] Ligand Pharmaceuticals Inc., Department of Pharmacology, San Diego, CA 92121

[3] Exelixis Inc., San Diego, CA 92121

[4] Universidade de Vigo, Departamento de Química Orgánica, Facultad de Química

[5] Department of Cancer Biology, Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67404 Illkirch Cedex

来源：

NATURE REVIEWS DRUG DISCOVERY | 2007年 / 6卷 / 10期

关键词：

D O I：

10.1038/nrd2397

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Retinoic acid receptors (RARs) are ligand-controlled transcription factors that function as heterodimers with retinoid X receptors (RXRs) to regulate cell growth and survival. The success of RAR modulation in the treatment of acute promyelocytic leukaemia (APL) has stimulated considerable interest in the development of RAR and RXR modulators. This has been aided by recent advances in the understanding of the biological role of RARs and RXRs and in the design of selective receptor modulators that might overcome the limitations of current drugs. Here, we discuss the challenges and opportunities for therapeutic strategies based on RXR and RAR modulators, with a focus on cancer and metabolic diseases such as diabetes and obesity.

引用

收藏

页码：793 / 810

页数：18

相关论文

共 187 条

[31]

Chun KH, 2003, CANCER RES, V63, P3826

[32] A novel atypical retinoid endowed with proapoptotic and antitumor activity [J].

Cincinelli, R ;

Dallavalle, S ;

Merlini, L ;

Penco, S ;

Pisano, C ;

Carminati, P ;

Giannini, G ;

Vesci, L ;

Gaetano, C ;

Illy, B ;

Zuco, V ;

Supino, R ;

Zunino, F .

JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (06) :909-912

[33] Tumor suppressor IRF-1 mediates retinoid and interferon anticancer signaling to death ligand TRAIL [J].

Clarke, N ;

Jimenez-Lara, AM ;

Voltz, E ;

Gronemeyer, H .

EMBO JOURNAL, 2004, 23 (15) :3051-3060

[34] Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor [J].

Claudel, T ;

Leibowitz, MD ;

Fiévet, C ;

Tailleux, A ;

Wagner, B ;

Repa, JJ ;

Torpier, G ;

Lobaccaro, JM ;

Paterniti, JR ;

Mangelsdorf, DJ ;

Heyman, RA ;

Auwerx, J .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2610-2615

[35] A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands [J].

Crowe, DL ;

Chandraratna, RA .

BREAST CANCER RESEARCH, 2004, 6 (05) :R546-R555

[36] Metabolic effects of rexinoids: Tissue-specific regulation of lipoprotein lipase activity [J].

Davies, PJA ;

Berry, SA ;

Shipley, GL ;

Eckel, RH ;

Hennuyer, N ;

Crombie, DL ;

Ogilvie, KM ;

Peinado-Onsurbe, J ;

Fievet, C ;

Leibowitz, MD ;

Heyman, RA ;

Auwerx, J .

MOLECULAR PHARMACOLOGY, 2001, 59 (02) :170-176

[37] 4-[3-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)phenyl]benzoic acid and heterocyclic-bridged analogues are novel retinoic acid receptor subtype and retinoid X receptor α agonists [J].

Dawson, MI ;

Jong, L ;

Hobbs, PD ;

Xiao, DM ;

Feng, KC ;

Chao, WR ;

Pan, C ;

Fontana, JA ;

Zhang, XK .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (12) :1311-1313

[38] Antagonist analogue of 6-[3′-(1-adamantyl)-4′-hydroxyphenyl]-2-naphthalenecarboxylic acid (AHPN) family of apoptosis inducers that effectively blocks AHPN-induced apoptosis but not cell-cycle arrest [J].

Dawson, MI ;

Harris, DL ;

Liu, G ;

Hobbs, PD ;

Lange, CW ;

Jong, L ;

Bruey-Sedano, N ;

James, SY ;

Zhang, XK ;

Peterson, VJ ;

Leid, M ;

Farhana, L ;

Rishi, AK ;

Fontana, JA .

JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) :3518-3536

[39] PML is a direct p53 target that modulates p53 effector functions [J].

de Stanchina, E ;

Querido, E ;

Narita, M ;

Davuluri, RV ;

Pandolfi, PP ;

Ferbeyre, G ;

Lowe, SW .

MOLECULAR CELL, 2004, 13 (04) :523-535

[40] Breast cancer prevention trials using retinoids [J].

Decensi, A ;

Serrano, D ;

Bonanni, B ;

Cazzaniga, M ;

Guerrieri-Gonzaga, A .

JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2003, 8 (01) :19-30

← 1 2 3 4 5 6 7 8 9 10 →